Drug interactions for the following drug(s)
Applies to: Spironolactone 50 MG Oral Tablet <> Yaz 28 Day Pack
The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Drospirenone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Spironolactone 50 MG Oral Tablet <> Yaz 28 Day Pack
Drug1 (rxcui = 198223, name = spironolactone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 748856, name = {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Yaz 28 Day], tty = BPCK). Drug1 is resolved to spironolactone, Drug2 is resolved to drospirenone and interaction asserted in DrugBank between Spironolactone and Drospirenone. Drug1 is resolved to ethinyl estradiol, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Ethinylestradiol and Spironolactone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.